F. Barry Bays, Director at TREACE MEDICAL CONCEPTS, INC. (TMCI), sold 19,928 shares at $20.10 ($401K) on 2022-08-29, disclosed to the SEC on 2022-08-31.
Open-market sale of $401k TMCI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.10 | 8,064 | $162K | 40.4% |
| 2 | $20.10 | 8,064 | $162K | 40.4% |
| 3 | $20.15 | 3,800 | $77K | 19.1% |
| Total | $20.11 avg | 19,928 | $401K | 100% |
| Filing → |
| TMCI | SELL | 2023-04-13 | $4.5M | — | Filing → |
| TMCI | SELL | 2023-03-30 | $3.0M | — | Filing → |
| TMCI | SELL | 2023-03-15 | $646K | — | Filing → |